Bayer, The German Pharma, Fights for its Future Amidst Legal Woes and Breakup Calls
Bayer AG (ETR: BAYN), the 162-year-old German conglomerate, is in the midst of a profound crisis of confidence, battling to redefine its future under the immense weight of the disastrous Monsanto acquisition. The company is now facing a perfect storm of relentless US litigation over the weedkiller Roundup, a depressed stock price, and intense pressure f…
Keep reading with a 7-day free trial
Subscribe to 🌍Emerging Alpha by AFYVA to keep reading this post and get 7 days of free access to the full post archives.